Trust Point Inc. Supernus Pharmaceuticals, Inc. Transaction History
Trust Point Inc.
- $1.25 Trillion
- Q2 2024
A detailed history of Trust Point Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Trust Point Inc. holds 16,241 shares of SUPN stock, worth $499,410. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,241
Previous 16,244
0.02%
Holding current value
$499,410
Previous $554 Million
21.59%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
257Shares Held
57.2MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$319 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$191 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$110 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$82.1 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$78.6 Million0.02% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.64B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...